Approval · Notice of Compliance 681 · 2002
ALKERAN: Notice of Compliance 681
Issued June 13, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 681
- Date
- June 13, 2002
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Reformulation of the 2mg tablet; new drug product manufacturing site; new drug substance manufacturing site
- Therapeutic class
- Antineoplastic (alkylating) agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALKERAN | Not yet assigned | — |
Medicinal ingredients
- MELPHALAN 2 MG per TAB